Press release
Peptide Therapeutics Market 2020 Size, Share, Trends, Latest Innovations, Drivers, Dynamics And Strategic Analysis, Challenges By 2025
New York, March 31, 2020: Global peptide therapeutics market share consists of several players including Eli Lilly and Company, Merck & Co, CordenPharma International, AstraZeneca Plc, Ipsen S.A, PolyPeptide Group, Teva Pharmaceutical, Bachem AG, and Novo Nordisk A/S.Global peptide therapeutics market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional peptide therapeutics market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Browse Full Report: https://www.marketresearchengine.com/peptide-therapeutics-market
Global peptide therapeutics market is segregated on the basis of applications as cancer, metabolic, CVD, respiratory, GIT, anti-infective, dermatology, CNS, and renal. Cancer is expected to witness notable gains in the forecast years. The report segments global peptide therapeutics market based on technology as liquid phase, solid phase, and hybrid phase.
The Peptide Therapeutics Market is expected to exceed more than US$ 45 bn by 2024. The market is predicted to register a promising 9% CAGR between 2018 and 2024. Surging importance peptide therapeutics in the treatment of several diseases including cancer, nervous system disorders, ovarian cancer, breast cancer, and gastrointestinal cancers are fuelling product landscape. Increasing R&D investment by the major companies for improving efficacy owing to the absence of toxicity in the product portfolio. It is leading towards the development of excellent peptide therapeutic drugs is projected to boost industry growth.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The global peptide therapeutics market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Company 1, Company 2, ...Company N.
Rising adoption of cost-effective measures by the physicians is accompanied by the risen healthcare expenditures from the several government authorities propelling product demand. Peptide consists of short amino acid monomer chains. However, production in large scale due to complexities peptide has become a major challenge for the biotech and pharmaceutical companies. New product developments such as multifunctional peptides through the hybrid technology are anticipated to drive market size.
The report covers:
o Global peptide therapeutics market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.
o Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
o Global peptide therapeutics market trends, with detailed analysis on consumer trends & manufacturer trends
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
o Key areas of investments identifying market opportunities and challenges in forecast timeframe
o Competitive analysis of the industry players along with the overview on strategic management
o Comprehensive company profiles of the major industry players
Reasons to Buy this Report:
o Gain comprehensive insights on the industry trends
o Identify industry opportunities and key growth segments
o Obtain complete market study on the peptide therapeutics market
o Facilitate strategy planning for your company based on the industry dynamics
o Evaluate your competitor's business segments and portfolios
The Peptide Therapeutics Market has been segmented as below:
The Peptide Therapeutics Market is segmented on the lines of Peptide Therapeutics Market, By Application, Peptide Therapeutics Market, By Route of Administration, Peptide Therapeutics Market, By Type, Peptide Therapeutics Market, By Technology, Peptide Therapeutics Market, By Type of Molecule, Peptide Therapeutics Market, By API Peptide Type and Peptide Therapeutics Market, By Region.
Peptide Therapeutics Market, By Application this market is segmented on the basis of Cancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS and Renal. Peptide Therapeutics Market, By Route of Administration this market is segmented on the basis of Parenteral and Oral. Peptide Therapeutics Market, By Type this market is segmented on the basis of Innovative and Generic. Peptide Therapeutics Market, By Technology this market is segmented on the basis of Liquid Phase, Solid Phase and Hybrid Phase. Peptide Therapeutics Market, By Type of Molecule this market is segmented on the basis of Vasopressin, Somatostatin, Calcitonin, Natriuretic and Immunopeptide. Peptide Therapeutics Market, By API Peptide Type this market is segmented on the basis of In-house and CMO. Peptide Therapeutics Market, By Region this market is segmented on the basis of North America, Europe, Asia Pacific and Rest of World.
Request Sample Report from here: https://bit.ly/2wHATwv
Table of Contents:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Driver 1
4.2.2. Driver 2
4.2.3. Driver 3
4.3. Restraints
4.3.1. Restraint 1
4.3.2. Restraint 2
4.4. Opportunities
4.4.1. Opportunity 1
4.4.2. Opportunity 2
4.5. Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
5. Peptide Therapeutics Market, By Application
6. Peptide Therapeutics Market, By Route of Administration
7. Peptide Therapeutics Market, By Type
8. Peptide Therapeutics Market, By Technology
9. Peptide Therapeutics Market, By Type of Molecule
10. Peptide Therapeutics Market,By API Peptide Type
11. Competitive Landscape
12. Company Profile
12.1. Eli Lilly and Company
12.1.1. Company Overview
12.1.2. Product/Service Landscape
12.1.3. Financial Overview
12.1.4. Recent Developments
12.2. Merck & Co
12.2.1. Company Overview
12.2.2. Product/Service Landscape
12.2.3. Financial Overview
12.2.4. Recent Developments
12.3. CordenPharma International
12.3.1. Company Overview
12.3.2. Product/Service Landscape
12.3.3. Financial Overview
12.3.4. Recent Developments
12.4. AstraZeneca Plc
12.4.1. Company Overview
12.4.2. Product/Service Landscape
12.4.3. Financial Overview
12.4.4. Recent Developments
12.5. Ipsen S.A
12.5.1. Company Overview
12.5.2. Product/Service Landscape
12.5.3. Financial Overview
12.5.4. Recent Developments
12.6. PolyPeptide Group
12.6.1. Company Overview
12.6.2. Product/Service Landscape
12.6.3. Financial Overview
12.6.4. Recent Developments
12.7. Teva Pharmaceutical
12.7.1. Company Overview
12.7.2. Product/Service Landscape
12.7.3. Financial Overview
12.7.4. Recent Developments
12.8. Bachem AG
12.8.1. Company Overview
12.8.2. Product/Service Landscape
12.8.3. Financial Overview
12.8.4. Recent Developments
12.9. Novo Nordisk A/S.
12.9.1. Company Overview
12.9.2. Product/Service Landscape
12.9.3. Financial Overview
12.9.4. Recent Developments
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market 2020 Size, Share, Trends, Latest Innovations, Drivers, Dynamics And Strategic Analysis, Challenges By 2025 here
News-ID: 1993326 • Views: …
More Releases from Market Research Engine - Report
Phacoemulsification Systems Market Growth, Ongoing Trends, Technological Innovat …
New York, March 31, 2020: The scope of the report includes a detailed study of Phacoemulsification Systems Market with the reasons given for variations in the growth of the industry in certain regions.
The Phacoemulsification Systems Market is segmented on the lines of its technology, component, vehicle type and regional. On the basis of product segmentation, it includes Ophthalmic Viscoelastic Device (OVD), Phacoemulsification Equipment and Other. Based on application classification…
Percussion Hammer Market 2020 Growth, Ongoing Trends, Technological Innovation, …
New York, March 31, 2020: The global Percussion Hammer market is segregated on the basis of Type as Round, Triangle, and Other. Based on End-User the global Percussion Hammer market is segmented in Hospitals, Orthopaedic Clinics, Ambulatory Surgical Centres, and Others.
The global Percussion Hammer market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Percussion Hammer market for each region is…
Pediatric X-Ray Positioning Chair Market 2020 Size, Share, Trends, Latest Innova …
New York, March 31, 2020: The global Pediatric X-Ray Positioning Chair market is segregated on the basis of Type as 38cm and 79 cm. Based on End-User the global Pediatric X-Ray Positioning Chair market is segmented in Hospital, Clinics, and Others.
The global Pediatric X-Ray Positioning Chair market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Pediatric X-Ray Positioning Chair market…
Patient-Controlled Analgesia Pumps Market 2020 Size, Share, Trends, Latest Innov …
New York, March 31, 2020: Global Patient-Controlled Analgesia Pumps Market is segregated on the basis of application as oncology, hematology, neonatology, gastroenterology and diabetes. Based on product type, the global Patient-Controlled Analgesia Pumps market is segmented in electronic PCA pumps and mechanical PCA pumps. The report also bifurcates global Patient-Controlled Analgesia Pumps market based on end user in hospitals, ambulatory surgical centers, home care settings and others.
The report scope…
More Releases for Peptide
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
There are two main types of products available in the customized peptide synthesis…
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample
The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected…
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,…
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future.
Click to Request a Sample:…
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market
Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug…